▶ 調査レポート

胃不全麻痺薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global Gastroparesis Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。胃不全麻痺薬の世界市場:市場規模・現状・予測 / Global Gastroparesis Drugs Market Size, Status and Forecast 2019-2025 / QYR9ST04846資料のイメージです。• レポートコード:QYR9ST04846
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、胃不全麻痺薬の世界市場について調査・分析し、胃不全麻痺薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(運動促進薬、制吐薬、ボツリヌス毒素注射、その他)、用途別(糖尿病性胃不全麻痺、特発性胃不全麻痺)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の胃不全麻痺薬市場動向
・主要企業別マーケットシェア
・胃不全麻痺薬の種類別市場規模2014-2019
(運動促進薬、制吐薬、ボツリヌス毒素注射、その他)
・胃不全麻痺薬の用途別市場規模2014-2019
(糖尿病性胃不全麻痺、特発性胃不全麻痺)
・胃不全麻痺薬の北米市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬の中国市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬の日本国内市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬の東南アジア市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬のインド市場:主要企業・種類別/用途別市場規模
・胃不全麻痺薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Cadila Pharmaceuticals、GlaxoSmithKline、Johnson & Johnson、Valeant、Evoke Pharma、Teva Pharmaceutical Industries、Theravance Biopharma)
・胃不全麻痺薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract.The idiopathic gastroparesis segment dominated the global gastroparesis drugs market during 2017 and the segment is expected to continue its dominance during the next few years as well. The market is witnessing the development of new and effective therapies for the symptomatic control of idiopathic gastroparesis, which will be one of the major factors responsible for the market segment’s growth.
The prokinetic agents segment accounted for the major shares of the gastroparesis drugs market and according to this market research and analysis, the segment will continue its market dominance during the next few years as well. Prokinetic agents are used to relieve a large number of gastrointestinal (GI) symptoms such as bloating, constipation, abdominal discomfort, vomiting, nausea, and heartburn.
In 2018, the global Gastroparesis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gastroparesis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroparesis Drugs development in United States, Europe and China.

The key players covered in this study
Cadila Pharmaceuticals
GlaxoSmithKline
Johnson & Johnson
Valeant
Evoke Pharma
Teva Pharmaceutical Industries
Theravance Biopharma

Market segment by Type, the product can be split into
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injection
Other

Market segment by Application, split into
Diabetic Gastroparesis
Idiopathic Gastroparesis

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastroparesis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Gastroparesis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastroparesis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastroparesis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Prokinetic Agents
1.4.3 Antiemetic Agents
1.4.4 Botulinum Toxin Injection
1.4.5 Other
1.5 Market by Application
1.5.1 Global Gastroparesis Drugs Market Share by Application (2014-2025)
1.5.2 Diabetic Gastroparesis
1.5.3 Idiopathic Gastroparesis
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gastroparesis Drugs Market Size
2.2 Gastroparesis Drugs Growth Trends by Regions
2.2.1 Gastroparesis Drugs Market Size by Regions (2014-2025)
2.2.2 Gastroparesis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gastroparesis Drugs Market Size by Manufacturers
3.1.1 Global Gastroparesis Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastroparesis Drugs Key Players Head office and Area Served
3.3 Key Players Gastroparesis Drugs Product/Solution/Service
3.4 Date of Enter into Gastroparesis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gastroparesis Drugs Market Size by Type (2014-2019)
4.2 Global Gastroparesis Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Gastroparesis Drugs Market Size (2014-2019)
5.2 Gastroparesis Drugs Key Players in United States
5.3 United States Gastroparesis Drugs Market Size by Type
5.4 United States Gastroparesis Drugs Market Size by Application

6 Europe
6.1 Europe Gastroparesis Drugs Market Size (2014-2019)
6.2 Gastroparesis Drugs Key Players in Europe
6.3 Europe Gastroparesis Drugs Market Size by Type
6.4 Europe Gastroparesis Drugs Market Size by Application

7 China
7.1 China Gastroparesis Drugs Market Size (2014-2019)
7.2 Gastroparesis Drugs Key Players in China
7.3 China Gastroparesis Drugs Market Size by Type
7.4 China Gastroparesis Drugs Market Size by Application

8 Japan
8.1 Japan Gastroparesis Drugs Market Size (2014-2019)
8.2 Gastroparesis Drugs Key Players in Japan
8.3 Japan Gastroparesis Drugs Market Size by Type
8.4 Japan Gastroparesis Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gastroparesis Drugs Market Size (2014-2019)
9.2 Gastroparesis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Gastroparesis Drugs Market Size by Type
9.4 Southeast Asia Gastroparesis Drugs Market Size by Application

10 India
10.1 India Gastroparesis Drugs Market Size (2014-2019)
10.2 Gastroparesis Drugs Key Players in India
10.3 India Gastroparesis Drugs Market Size by Type
10.4 India Gastroparesis Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Gastroparesis Drugs Market Size (2014-2019)
11.2 Gastroparesis Drugs Key Players in Central & South America
11.3 Central & South America Gastroparesis Drugs Market Size by Type
11.4 Central & South America Gastroparesis Drugs Market Size by Application

12 International Players Profiles
12.1 Cadila Pharmaceuticals
12.1.1 Cadila Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastroparesis Drugs Introduction
12.1.4 Cadila Pharmaceuticals Revenue in Gastroparesis Drugs Business (2014-2019)
12.1.5 Cadila Pharmaceuticals Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastroparesis Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Gastroparesis Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastroparesis Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Gastroparesis Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Valeant
12.4.1 Valeant Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastroparesis Drugs Introduction
12.4.4 Valeant Revenue in Gastroparesis Drugs Business (2014-2019)
12.4.5 Valeant Recent Development
12.5 Evoke Pharma
12.5.1 Evoke Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastroparesis Drugs Introduction
12.5.4 Evoke Pharma Revenue in Gastroparesis Drugs Business (2014-2019)
12.5.5 Evoke Pharma Recent Development
12.6 Teva Pharmaceutical Industries
12.6.1 Teva Pharmaceutical Industries Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastroparesis Drugs Introduction
12.6.4 Teva Pharmaceutical Industries Revenue in Gastroparesis Drugs Business (2014-2019)
12.6.5 Teva Pharmaceutical Industries Recent Development
12.7 Theravance Biopharma
12.7.1 Theravance Biopharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastroparesis Drugs Introduction
12.7.4 Theravance Biopharma Revenue in Gastroparesis Drugs Business (2014-2019)
12.7.5 Theravance Biopharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gastroparesis Drugs Key Market Segments
Table Key Players Gastroparesis Drugs Covered
Table Global Gastroparesis Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastroparesis Drugs Market Size Market Share by Type 2014-2025
Figure Prokinetic Agents Figures
Table Key Players of Prokinetic Agents
Figure Antiemetic Agents Figures
Table Key Players of Antiemetic Agents
Figure Botulinum Toxin Injection Figures
Table Key Players of Botulinum Toxin Injection
Figure Other Figures
Table Key Players of Other
Table Global Gastroparesis Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Diabetic Gastroparesis Case Studies
Figure Idiopathic Gastroparesis Case Studies
Figure Gastroparesis Drugs Report Years Considered
Table Global Gastroparesis Drugs Market Size 2014-2025 (Million US$)
Figure Global Gastroparesis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastroparesis Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Gastroparesis Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Gastroparesis Drugs Market Share by Regions 2014-2019
Figure Global Gastroparesis Drugs Market Share by Regions 2014-2019
Figure Global Gastroparesis Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Gastroparesis Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastroparesis Drugs Market Share by Manufacturers (2014-2019)
Figure Global Gastroparesis Drugs Market Share by Manufacturers in 2018
Table Global Gastroparesis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastroparesis Drugs Product/Solution/Service
Table Date of Enter into Gastroparesis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Gastroparesis Drugs Market Size Share by Type (2014-2019)
Figure Global Gastroparesis Drugs Market Size Market Share by Type (2014-2019)
Table Global Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Gastroparesis Drugs Market Size Share by Application (2014-2019)
Figure Global Gastroparesis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Gastroparesis Drugs Revenue Market Share by Application in 2018
Figure United States Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Gastroparesis Drugs Market Share (2018-2019)
Table United States Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Gastroparesis Drugs Market Share by Type (2014-2019)
Table United States Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Gastroparesis Drugs Market Share by Application (2014-2019)
Figure Europe Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastroparesis Drugs Market Share (2018-2019)
Table Europe Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Gastroparesis Drugs Market Share by Type (2014-2019)
Table Europe Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Gastroparesis Drugs Market Share by Application (2014-2019)
Figure China Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Gastroparesis Drugs Market Share (2018-2019)
Table China Gastroparesis Drugs Market Size by Type (2014-20189) (Million US$)
Table China Gastroparesis Drugs Market Share by Type (2014-2019)
Table China Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Gastroparesis Drugs Market Share by Application (2014-2019)
Figure Japan Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastroparesis Drugs Market Share (2018-2019)
Table Japan Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Gastroparesis Drugs Market Share by Type (2014-2019)
Table Japan Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Gastroparesis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastroparesis Drugs Market Share (2018-2019)
Table Southeast Asia Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastroparesis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastroparesis Drugs Market Share by Application (2014-2019)
Figure India Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Gastroparesis Drugs Market Share (2018-2019)
Table India Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Gastroparesis Drugs Market Share by Type (2014-2019)
Table India Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Gastroparesis Drugs Market Share by Application (2014-2019)
Figure Central & South America Gastroparesis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastroparesis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastroparesis Drugs Market Share (2018-2019)
Table Central & South America Gastroparesis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastroparesis Drugs Market Share by Type (2014-2019)
Table Central & South America Gastroparesis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastroparesis Drugs Market Share by Application (2014-2019)
Table Cadila Pharmaceuticals Company Details
Table Cadila Pharmaceuticals Revenue in Gastroparesis Drugs Business (2014-2019) (Million US$)
Figure Cadila Pharmaceuticals Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Cadila Pharmaceuticals Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Valeant Company Details
Table Valeant Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure Valeant Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Valeant Recent Development
Table Evoke Pharma Company Details
Table Evoke Pharma Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure Evoke Pharma Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Evoke Pharma Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Theravance Biopharma Company Details
Table Theravance Biopharma Revenue in Gastroparesis Drugs Business (2014-2019)(Million US$)
Figure Theravance Biopharma Revenue Growth Rate in Gastroparesis Drugs Business (2014-2019)
Table Theravance Biopharma Recent Development
Table Global Gastroparesis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Gastroparesis Drugs Market Size Share by Regions (2019-2025)
Figure Global Gastroparesis Drugs Market Size Share by Regions in 2025
Figure United States Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastroparesis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Gastroparesis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Gastroparesis Drugs Market Size by Product (2019-2025)
Figure Global Gastroparesis Drugs Market Size by Product in 2025
Table Global Gastroparesis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Gastroparesis Drugs Market Size by Application (2019-2025)
Figure Global Gastroparesis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources